Egyptian President appreciates Indian pharma firms contribution

The Indian Embassy in a tweet said that 26 Indian companies participated in the event.

Published On 2022-06-09 04:30 GMT   |   Update On 2022-06-09 04:30 GMT
Advertisement

New Delhi: In rare honour, Egyptian President Abdel Fattah El Sisi visited the Indian pavilion at the first Africa Health ExCon 2022 held in Cairo and appreciated the contribution of Indian pharma companies in the pharmaceutical sector in Egypt.

The Indian Embassy in a tweet said that 26 Indian companies participated in the event.
"26 Indian companies under PHARMEXCIL participated in the 1st #AfricaHealthExCon2022 held in Cairo from 5-7 June 2022. President Abdel Fattah El Sisi visited the Indian Pavilion and appreciated the contribution of Indian Pharma Companies in the pharmaceutical sector in Egypt," it said in a tweet.
Advertisement
The event, held at Al-Manara International Conference Centre in New Cairo, was inaugurated by President El Sisi on Sunday.
Around 2,000 delegates representing government health entities from Africa and the Middle East participated in the conference, which was organised by the Egyptian Authority for Unified Procurement and is the biggest medical exhibition and conference on the continent.
Over 350 companies operating in more than 102 countries took part in the conference, unveiling the latest medical technologies and outlining the best practices for sustainable healthcare on the continent.
The conference included 350 sessions and 20 workshops featuring more than 800 international speakers and medical experts, with the aim of showcasing the latest technologies in the field of medicine as well as initiatives that support Africa ExCon as a sustainable platform that connects international healthcare partners.
Acting Health Minister Khaled Abdel-Ghaffar said Egypt will host the second edition of Africa Health ExCon on June 8 2023.

Read also: Govt picks top 300 drug brands including Dolo, Saridon, FabiFlu to issue unique QR code

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News